Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lymphoma Clinical Trials in Denver | 209 Studies

Clinical Trials LymphomaDenver

Lymphoma Clinical Trials in Denver

Find 209 clinical trials for lymphoma near Denver, Colorado. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Denver

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 209 trials

CompletedOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in…NCT03233204·Birmingham, Alabama and 112 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedMobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma PatientsThe purpose of this study is to determine whether the combination of AMD3100 (plerixafor) and granulocyte colony-stimulating factor (G-CSF or generic name filgrastim) is better…NCT00103610·Phoenix, Arizona and 31 others

CompletedRosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseRosiglitazone (RSG) has been tested and is approved as a treatment for type II diabetes mellitus, a disease that occurs when the body ineffectively uses glucose.NCT00428090·Phoenix, Arizona and 137 others

Approved for marketingAn Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell LymphomaThe purpose of this study is to provide patients who have relapsed or refractory Mantle Cell Lymphoma (MCL) with early access to an investigational medication called ibrutinib…NCT01833039·Phoenix, Arizona and 50 others

CompletedIbrutinib With Rituximab in Adults With Waldenström's MacroglobulinemiaThe purpose of this study is to evaluate the safety and efficacy of ibrutinib in combination with rituximab in participants with Waldenström's macroglobulinemia (WM).NCT02165397·Los Angeles, California and 47 others

RecruitingSafety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory LymphomaThis study is a Phase 1 multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patients with Relapsed or Refractory…NCT05798897·Duarte, California and 6 others

Active not recruitingRituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete RemissionThis phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual…NCT03267433·Birmingham, Alabama and 374 others

TerminatedReduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaRATIONALE: Photopheresis allows patient white blood cells to be treated with ultraviolet (UV) light and drugs outside the body to inactivate T cells.NCT00057954·Aurora, Colorado and 18 others

Active not recruitingInotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaThis phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with B-lymphoblastic lymphoma or CD22 positive B acute lymphoblastic leukemia that…NCT02981628·Birmingham, Alabama and 156 others

TerminatedPhase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's LymphomaThe purpose of this study is to determine the optimal dose of Campath for patients with relapsing or refractory (failed standard therapy) non-Hodgkin's lymphoma.NCT00051701·Aurora, Colorado and 16 others

TerminatedAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesThis was a study of INCB054329 given to patients with advanced malignancies that were conducted in three treatment groups.NCT02431260·Los Angeles, California and 11 others

CompletedA Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)A phase 1, dose escalation study of evorpacept (ALX148) in patients with advanced solid tumors and lymphomaNCT03013218·Denver, Colorado and 9 others

CompletedCombination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsThis randomized phase III trial studies how well combination chemotherapy works in treating young patients with newly diagnosed B acute lymphoblastic leukemia that is likely to…NCT02883049·Birmingham, Alabama and 238 others

CompletedA Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin LymphomaThis was a Phase 2 clinical trial to evaluate the safety and efficacy of duvelisib as a monotherapy in participants with indolent non-Hodgkin lymphoma (iNHL) (follicular lymphoma…NCT01882803·Los Angeles, California and 68 others

TerminatedPhase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCLAFM13-203 is a phase 2, open-label, multi-center, multi-cohort study with a safety run-in followed by expansion cohorts.NCT05883449·Birmingham, Alabama and 14 others

CompletedPhase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapyPhase III study of RAD001 adjuvant therapy in poor risk patients with Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 versus matching placebo after patients had achieved complete…NCT00790036·Chandler, Arizona and 201 others

CompletedS9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.NCT00003784·Mobile, Alabama and 86 others

CompletedMonoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaRATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00301821·Scottsdale, Arizona and 161 others

CompletedDonor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological MalignanciesThis phase II trial studies how well donor atorvastatin treatment works in preventing severe graft-versus-host disease (GVHD) after nonmyeloablative peripheral blood stem cell…NCT01527045·Denver, Colorado and 1 other

CompletedRituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00460109·Scottsdale, Arizona and 164 others

PreviousPage 8 of 11Next

Other Conditions in Denver

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia